Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Horowitz

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
African Journal of Primary Health Care & Family Medicine|April 2, 2026
Stopping antidepressants safelyMark Horowitz, Thomas L Perry
Urology Case Reports|March 24, 2017
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical StainingMelissa Dundas, Mark Horowitz, Richard Sidlow
Adipocyte|May 24, 2013
WAT is a functional adipocyte?Christopher Church, Mark Horowitz, Matthew Rodeheffer
Endocrine Reviews|May 3, 2008
Osteoimmunology: interactions of the bone and immune systemJoseph Lorenzo, Mark Horowitz, Yongwon Choi
Journal of Structural Biology|January 18, 2012
Removing high contrast artifacts via digital inpainting in cryo-electron tomography: an application of compressed sensingKahye Song, Luis R Comolli, Mark Horowitz
Frontiers in Neuroinformatics|January 9, 2019
Mapping Histological Slice Sequences to the Allen Mouse Brain Atlas Without 3D ReconstructionJing Xiong, Jing Ren, Liqun Luo, et al.
Psychiatry Research|June 26, 2023
The need for antidepressant withdrawal support services: Recommendations from 708 patientsJohn Read, Stevie Lewis, Mark Horowitz, et al.
Therapeutic Advances in Psychopharmacology|November 23, 2020
The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical conditionAnne Guy, Marion Brown, Stevie Lewis, et al.
Lancet (London, England)|October 11, 2020
Lack of safeguards in response to restrictive public health measuresRobert Freudenthal, Mark Horowitz, Sushrut Jadhav, et al.
Expert Opinion on Pharmacotherapy|August 18, 2021
Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indicationJohn Davis, Daisy Zamora, Mark Horowitz, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
African Journal of Primary Health Care & Family Medicine|April 2, 2026
Stopping antidepressants safelyMark Horowitz, Thomas L Perry
Urology Case Reports|March 24, 2017
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical StainingMelissa Dundas, Mark Horowitz, Richard Sidlow
Adipocyte|May 24, 2013
WAT is a functional adipocyte?Christopher Church, Mark Horowitz, Matthew Rodeheffer
Endocrine Reviews|May 3, 2008
Osteoimmunology: interactions of the bone and immune systemJoseph Lorenzo, Mark Horowitz, Yongwon Choi
Journal of Structural Biology|January 18, 2012
Removing high contrast artifacts via digital inpainting in cryo-electron tomography: an application of compressed sensingKahye Song, Luis R Comolli, Mark Horowitz
Frontiers in Neuroinformatics|January 9, 2019
Mapping Histological Slice Sequences to the Allen Mouse Brain Atlas Without 3D ReconstructionJing Xiong, Jing Ren, Liqun Luo, et al.
Psychiatry Research|June 26, 2023
The need for antidepressant withdrawal support services: Recommendations from 708 patientsJohn Read, Stevie Lewis, Mark Horowitz, et al.
Therapeutic Advances in Psychopharmacology|November 23, 2020
The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical conditionAnne Guy, Marion Brown, Stevie Lewis, et al.
Lancet (London, England)|October 11, 2020
Lack of safeguards in response to restrictive public health measuresRobert Freudenthal, Mark Horowitz, Sushrut Jadhav, et al.
Expert Opinion on Pharmacotherapy|August 18, 2021
Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indicationJohn Davis, Daisy Zamora, Mark Horowitz, et al.
Pageof 9